RecallHawk

LO LOESTRIN FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE)

APIL

Summary

FDA approved LO LOESTRIN FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE) by APIL. NDA (New Drug) approval (Labeling) on 2022-04-29. TABLET, ORAL.

Details

Source

Drug Approval

External ID

NDA022501-15

Action Date

2022-04-29

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

LO LOESTRIN FE (generic: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE), TABLET, ORAL. Application: NDA022501

Company

Context & Analysis

APIL has 4 FDA actions in our database.

Frequently Asked Questions

How often does APIL have FDA actions?

APIL has 4 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA022501-15" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions